MSD's pulmonary arterial hypertension (PAH) drug Winrevair has been accelerating at a breakneck pace since its launch earlier this year – and data from a new phase 3 study could give it a turbo ...

As the noise became more untenable, I decided to pull the engine. At some point in its history ... and I delivered the fuel-injection pump to a shop over 400 miles from my home to another highly ...

Javascript is required for the SCS calendar.